‘I think we will have the votes’: Sanders gears up to sub­poe­na CEOs of J&J, Mer­ck to tes­ti­fy on drug prices

Last year
Pharma
FDA+

Bris­tol My­ers de­buts first TV ad for heart con­di­tion drug Camzyos

Last year
Pharma
Marketing

Gener­ic in­dus­try group sues Illi­nois over drug price law

Last year
Pharma
Law

J&J con­tin­ues build­ing out pso­ri­a­sis im­age li­brary with di­verse skin types

Last year
Pharma
Marketing

As­traZeneca builds in­to Chi­na; Eli Lil­ly hit with 483; GSK’s new col­lab­o­ra­tion 

Last year
Manufacturing

Lentivi­ral vec­tor short­age looms un­less man­u­fac­tur­ing hur­dles from clin­i­cal to com­mer­cial are ad­dressed

Last year
Manufacturing

Is CG On­col­o­gy’s IPO a bench­mark for a bet­ter year in pub­lic of­fer­ings? 

Last year
Financing

Glen­mark, Al­pham­ab deal worth up to $700M; Tour­ma­line’s $150M of­fer­ing; Re­pare records $40M mile­stone

Last year
News Briefing

Shang­hai star­tup's gene ther­a­py re­stores hear­ing in five deaf chil­dren, run­ning ahead of Lil­ly and Re­gen­eron tri­als

Last year
R&D
Cell/Gene Tx

Head­space plans to be cash-flow pos­i­tive in the first quar­ter of 2024

Last year
Health Tech

Roche and Ex­elix­is de­tail rare suc­cess for Cabome­tyx-Tecen­triq com­bo in prostate can­cer

Last year
R&D
Pharma

Kyver­na says CAR-T man­u­fac­tur­ing times can be cut through blood col­lec­tion ef­fi­cien­cies 

Last year
Manufacturing

Biotech's 2024 IPO sea­son kicks off with heavy de­mand for CG On­col­o­gy in $380M list­ing

Last year
Financing

Ex­clu­sive: Teladoc makes job cuts, elim­i­nates some roles in en­gi­neer­ing and da­ta sci­ence

Last year
People
Health Tech

Fol­low­ing CAR-T safe­ty la­bel changes, FDA of­fi­cials share new de­tails about sec­ondary can­cer cas­es

Last year
Pharma
Cell/Gene Tx

Au­vi-q al­ler­gy in­jec­tor re­cruits Brit­tany Ma­homes for new cam­paign

Last year
Pharma
Marketing

On­col­o­gists want more treat­ment op­tions for ad­vanced lung can­cer pa­tients, new sur­vey says

Last year
Pharma
Marketing

Dan­co to SCO­TUS: Abor­tion pill re­stric­tions could 'desta­bi­lize the phar­ma­ceu­ti­cal in­dus­try'

Last year
Pharma
Law

FDA up­dates Gilead­'s la­bel for CAR-T Tecar­tus with new boxed warn­ing for sec­ondary can­cer

Last year
Pharma
Cell/Gene Tx

Phar­ma com­pa­nies to re­main mum on CM­S' ini­tial of­fers next week for the first year of IRA ne­go­ti­a­tions

Last year
FDA+
Law

CMC con­cerns lead to FDA re­jec­tion of Ther­at­e­ch­nolo­gies’ con­cen­trat­ed ver­sion of lipody­s­tro­phy drug for HIV ...

Last year
FDA+
Manufacturing

Ku­ra’s $150M PIPE; Lil­ly’s in­vest­ment in Prism Bi­o­Lab; An­no­vis de­lays PhI­II da­ta, cit­ing ‘da­ta clean­ing’

Last year
News Briefing

De­spite CD­MO head­winds, Sam­sung Bio re­ports 2023 rev­enue jump and pre­dicts even more gains this year

Last year
Manufacturing

LB Phar­ma­ceu­ti­cals clos­es $75M Se­ries C as it be­gins PhII schiz­o­phre­nia tri­al

Last year
Financing
Startups
First page Previous page 212213214215216217218 Next page Last page
A service from the Financial Times